Esther E. Freeman
#89,024
Most Influential Person Now
Researcher
Esther E. Freeman's AcademicInfluence.com Rankings
Esther E. Freemanmedical Degrees
Medical
#1836
World Rank
#2214
Historical Rank
#429
USA Rank
Dermatology
#46
World Rank
#62
Historical Rank
#9
USA Rank
Public Health
#644
World Rank
#664
Historical Rank
#99
USA Rank
Epidemiology
#830
World Rank
#865
Historical Rank
#123
USA Rank
Esther E. Freemanphilosophy Degrees
Philosophy
#9427
World Rank
#12983
Historical Rank
#1764
USA Rank
Logic
#8608
World Rank
#10791
Historical Rank
#1436
USA Rank
Download Badge
Medical Philosophy
Esther E. Freeman's Degrees
- Doctorate Medicine Harvard University
Why Is Esther E. Freeman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Esther Ellen Freeman is an American physician who is an Assistant Professor of Dermatology at the Harvard Medical School and Director of Global Health Dermatology at Massachusetts General Hospital. Her research considers HIV infection with AIDS-defining malignancies, including Kaposi's sarcoma. During the COVID-19 pandemic Freeman established the American Academy of Dermatology register of COVID-19 skin complaints, through which she identified the novel symptom of COVID toes.
Esther E. Freeman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies (2006) (1204)
- Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases (2021) (567)
- The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries (2020) (279)
- Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 (2021) (191)
- Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries (2020) (172)
- Global Burden of Skin Disease: Inequities and Innovations (2017) (157)
- Global resource shortages during COVID-19: Bad news for low-income countries (2020) (140)
- Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics (2007) (126)
- Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? (2008) (114)
- Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study (2020) (112)
- Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study (2007) (102)
- Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. (2014) (94)
- Treating Curable Sexually Transmitted Infections to Prevent HIV in Africa: Still an Effective Control Strategy? (2008) (81)
- Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study (2021) (79)
- Long COVID in the skin: a registry analysis of COVID-19 dermatological duration (2021) (76)
- Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination (2021) (59)
- Factors affecting HIV concordancy in married couples in four African cities (2004) (50)
- The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19 (2020) (50)
- Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa (2009) (49)
- COVID-19 Vaccines and the Skin (2021) (43)
- Varicella‐zoster and herpes simplex virus reactivation post‐COVID‐19 vaccination: a review of 40 cases in an International Dermatology Registry (2021) (37)
- The role of systematic reviews and meta-analysis in dermatology. (2012) (33)
- Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa (2008) (30)
- A positively selected FBN1 missense variant reduces height in Peruvian individuals (2020) (25)
- Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa (2016) (24)
- Pernio after COVID‐19 vaccination (2021) (24)
- Guidelines of care for the management of actinic keratosis. (2021) (23)
- Monkeypox emerges on a global scale: A historical review and dermatologic primer (2022) (23)
- Timing of PCR and antibody testing in patients with COVID-19–associated dermatologic manifestations (2020) (17)
- Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease (2020) (15)
- Cold and COVID: recurrent pernio during the COVID‐19 pandemic (2021) (13)
- International collaboration and rapid harmonization across dermatologic COVID-19 registries (2020) (13)
- A seat at the big table: expanding the role of dermatology at the World Health Organization and beyond. (2014) (13)
- Skin reactions to COVID-19 vaccines: An American Academy of Dermatology/International League of Dermatological Societies registry update on reaction location and COVID vaccine type (2021) (12)
- Attempting to explain heterogeneous HIV epidemics in sub-Saharan Africa: potential role of historical changes in risk behaviour and male circumcision (2011) (12)
- Task Shifting in Dermatology: A Call to Action. (2017) (10)
- Emerging Evidence of the Direct Association Between COVID-19 and Chilblains. (2020) (10)
- HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management (2019) (9)
- Skin Reactions to COVID-19 Vaccines: an AAD/ILDS Registry Update on reaction location and COVID vaccine type (2021) (8)
- Cutaneous Manifestations of SARS‐CoV‐2 infection during the Delta and Omicron waves in 348,691 UK users of the UK ZOE COVID Study App (2022) (8)
- Treatment of Dermatological Conditions Associated with HIV/AIDS: The Scarcity of Guidance on a Global Scale (2016) (7)
- Beyond T Staging in the “Treat-All” Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa (2021) (7)
- Delayed Large Local Reactions to mRNA Vaccines. Reply. (2021) (7)
- Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa (2017) (7)
- A positively selected, common, missense variant in FBN1 confers a 2.2 centimeter reduction of height in the Peruvian population (2019) (7)
- Urticaria 12 Days After COVID-19 mRNA Booster Vaccination. (2022) (7)
- Feasibility and implementation of portable confocal microscopy for point-of-care diagnosis of cutaneous lesions in a low-resource setting. (2020) (6)
- Modernizing Clinical Practice Guidelines for the American Academy of Dermatology. (2020) (6)
- Real-world use of chemotherapy for Kaposi’s sarcoma in a large community-based HIV primary care system in Kenya (2020) (6)
- Chronic spontaneous urticaria after COVID-19 primary vaccine series and boosters (2022) (5)
- Dermatology COVID-19 Registries (2021) (5)
- Learning from disease registries during a pandemic: Moving toward an international federation of patient registries (2021) (5)
- Cutaneous reactions following booster dose administration of COVID-19 mRNA vaccine: A first look from the American Academy of Dermatology/International League of Dermatologic Societies registry (2022) (5)
- Vitiligo of the arm after COVID-19 vaccination (2022) (5)
- Urticaria and/or angioedema secondary to mRNA COVID‐19 vaccines: Updates from a United States case registry (2022) (4)
- The role of herpes simplex virus Type 2 in the spread and control of HIV in four Sub-Saharan African Cities. (2006) (3)
- Novel Diagnostics for Kaposi Sarcoma and Other Skin Diseases in Resource-Limited Settings. (2021) (3)
- Global disparities in skin cancer services at HIV treatment centers across 29 countries. (2021) (3)
- Delayed large local reactions to Moderna COVID-19 vaccine: A follow-up report after booster vaccination (2022) (3)
- Developing a Platform for Global Health Dermatology Mentorship and Collaboration: Introducing the International Alliance for Global Health Dermatology. (2021) (3)
- Proposing a standardized assessment of COVID-19 vaccine-associated cutaneous reactions (2022) (2)
- The dynamics of monkeypox transmission (2022) (2)
- Cutaneous Reactions Following Booster Dose Administration of COVID-19 mRNA Vaccine: a first look from the AAD/ILDS Registry (2022) (2)
- Feasibility of Rapid Case Ascertainment for Cancer in East Africa: An Investigation of Community-Representative Kaposi Sarcoma in the Era of Antiretroviral Therapy. (2021) (2)
- Time to address disparities in the standard of care for Kaposi sarcoma (2020) (2)
- 217 Real-world chemotherapy adherence for Kaposi’s sarcoma in Sub-Saharan Africa (2019) (2)
- A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: Skin lesion morphology, clinical course, and scarring (2023) (2)
- 25 Years of Kaposi Sarcoma Herpesvirus: Discoveries, Disparities, and Diagnostics (2020) (2)
- Guidelines of Care for the Management of Actinic Keratosis: Executive Summary. (2021) (2)
- Skin Biopsy Equipment Availability Across 7 Low-Income Countries: A Cross-Sectional Study of 6053 Health Facilities. (2021) (2)
- How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World (2021) (2)
- Understanding Diagnostic Delays for Kaposi Sarcoma in Kenya: A Qualitative Study (2022) (2)
- The role of dermatology in Kaposi sarcoma diagnosis across three regions in sub-Saharan Africa. (2020) (2)
- Monkeypox emerges on a global scale: A historical review and dermatologic primer (2022) (1)
- Beyond T Staging in the Treat All Era: Capturing the Severity and Heterogeneity of Kaposi’s Sarcoma in East Africa (2020) (1)
- Dermatology on the global stage: The role of dermatologists in international health advocacy and COVID-19 research (2021) (1)
- The effects of systemic immunomodulatory treatments on COVID‐19 outcomes in patients with atopic dermatitis: results from the global SECURE‐AD registry (2022) (1)
- The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infections (2022) (1)
- Four cities modelling: #5 simulated effect of HSV-2 prophylactic vaccines on population-level HIV incidence in sub-Saharan Africa. (2006) (1)
- Response to: “Comment on ‘The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries’” (2021) (1)
- Identifying gaps in global health dermatology: a survey of GLODERM members (2021) (1)
- Telling the story of intersectional stigma in HIV‐associated Kaposi's sarcoma in western Kenya: a convergent mixed‐methods approach (2022) (1)
- Differential SARS-CoV-2 Antibody Profiles after Allergic Reactions to mRNA COVID-19 Vaccine. (2022) (1)
- Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. (2014) (1)
- Barriers and facilitators to chemotherapy initiation and adherence for patients with HIV-associated Kaposi’s sarcoma in Kenya: a qualitative study (2022) (1)
- Introducing the Global Health and Equity section in the British Journal of Dermatology (2022) (1)
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin (2022) (0)
- The BJD's approach to global health and equity in publishing: adding author reflexivity statements. (2023) (0)
- Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa (2016) (0)
- Supplement to "Clinical and Pathologic Correlation of Cutaneous COVID-19 Vaccine Reactions including V-REPP: A Registry Based Study" (2021) (0)
- Task Shifting in Dermatology-A Call to Action-Reply. (2018) (0)
- 729 Understanding the intersectional stigma of HIV-related dermatologic disorders in Kenya (2020) (0)
- Supplement 1: The GRADE Process (2020) (0)
- Factors associated with hospitalization due to COVID-19 in patients with psoriasis: insights from a global registry (2020) (0)
- Urticaria after COVID-19 vaccination and vaccine hesitancy (2022) (0)
- International Collaboration and Rapid Harmonization across Dermatologic COVID-19 Registries: Supplemental Appendix (2020) (0)
- COVID-19 and the Dermatologist (2021) (0)
- Four cities modelling: #1 rationale, methods and summary of results. (2006) (0)
- COVID-19 and the skin, three years on: long term impacts, emerging trends and clinical practice. (2023) (0)
- Nodules in a sporotrichoid (lymphangitic) distribution (2022) (0)
- Healthcare Costs and Financial Barriers to Diagnosis and Treatment of People Living with HIV-Associated Kaposi’s Sarcoma in Western Kenya: A Qualitative Analysis (2022) (0)
- Supplemental Appendix for "The role of dermatology in Kaposi sarcoma diagnosis across three regions in sub-Saharan Africa" (2020) (0)
- HIV in married couples: Factors affecting concordancyand discordancy in four African cities (2003) (0)
- Four cities modelling: #3 the changing role of direct and STI-mediated effects of male circumcision on HIV incidence during epidemics in sub-Saharan Africa. (2006) (0)
- A type III effectiveness-implementation hybrid evaluation of a multicomponent patient navigation strategy for advanced-stage Kaposi’s sarcoma: protocol (2022) (0)
- COVID-19 and Dermatology: One Year in Review (2021) (0)
- Four cities modelling: #2 the dynamic impact of male circumcision and curable STIs on the heterogeneity of HIV epidemics in sub-Saharan Africa - simulation results. (2006) (0)
- Real-world use of chemotherapy for Kaposi’s sarcoma in a large community-based HIV primary care system in Kenya (2020) (0)
- Urticaria After COVID-19 Vaccination and Vaccine Hesitancy (2023) (0)
- Migrant skin health - Perspectives from the Migrant Health Summit, Malta, 2022. (2023) (0)
- 168 COVID-19 mRNA vaccine booster cutaneous reactions reported to the AAD/ILDS dermatology registry (2022) (0)
- Hair and nail reactions represent a small proportion of all COVID‐19 dermatologic reactions in an analysis of an international COVID‐19 dermatological registry (2022) (0)
- Barriers and facilitators to chemotherapy initiation and adherence for patients with HIV-associated Kaposi’s sarcoma in Kenya: a qualitative study (2022) (0)
- 325 Kaposis sarcoma severity, treatment and survival in a large community-based HIV health care network in Kenya (2018) (0)
- Stigma in the Diagnosis and Treatment of HIV-associated Kaposi’s Sarcoma (2022) (0)
- The impact of the American Academy of Dermatology/International League of Dermatological Societies COVID-19 registry during the pandemic: 2500 cases across 72 countries (2023) (0)
- 26948 Identifying gaps in global health dermatology: A survey of GLODERM members (2021) (0)
- 339 Interdisciplinary dermatologic and wound care needs assessment in Western Kenya (2018) (0)
This paper list is powered by the following services:
Other Resources About Esther E. Freeman
What Schools Are Affiliated With Esther E. Freeman?
Esther E. Freeman is affiliated with the following schools:
